These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 2459854)
1. [Interferon therapy in hematologic neoplasms]. Schwarzinger I; Bettelheim P; Lechner K Wien Klin Wochenschr; 1988 Aug; 100(15):497-504. PubMed ID: 2459854 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of hematologic diseases with alpha interferon]. Castaigne S Bull Cancer; 1988; 75(9):859-62. PubMed ID: 3207895 [TBL] [Abstract][Full Text] [Related]
3. Biotherapy with interferon in hematologic malignancies. Roth MS; Foon KA Oncol Nurs Forum; 1987; 14(6 Suppl):16-22. PubMed ID: 2447569 [No Abstract] [Full Text] [Related]
4. Biotherapy with interferon--1988. Figlin RA Semin Oncol; 1988 Dec; 15(6 Suppl 6):3-9. PubMed ID: 2462749 [TBL] [Abstract][Full Text] [Related]
5. [Various aspects and results of therapy with interferon]. Niederle N Arzneimittelforschung; 1988 Mar; 38(3A):449-53. PubMed ID: 2456071 [TBL] [Abstract][Full Text] [Related]
6. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin]. Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434 [TBL] [Abstract][Full Text] [Related]
7. [Interferons. Treatment of malignant hemopathies with interferons]. Guilhot F; Sadoun A; Delwail V Ann Med Interne (Paris); 1993; 144(8):548-56. PubMed ID: 7513980 [TBL] [Abstract][Full Text] [Related]
8. Interferon therapy in cancer: from imaginon to interferon. Goldstein D; Laszlo J Cancer Res; 1986 Sep; 46(9):4315-29. PubMed ID: 2425950 [No Abstract] [Full Text] [Related]
9. [Use of interferon in patients with hairy cell leukemia and myeloproliferative disorders]. Skotnicki AB; Wolska-Smoleń T Acta Haematol Pol; 1994; 25(2 Suppl 1):124-35. PubMed ID: 8067197 [TBL] [Abstract][Full Text] [Related]
10. [Interferon (IFN) in multiple myeloma and non-Hodgkin's lymphoma]. Gola A Acta Haematol Pol; 1994; 25(2 Suppl 1):136-41. PubMed ID: 7520658 [TBL] [Abstract][Full Text] [Related]
11. The clinical application of the interferons: a review. NSW Therapeutic Assessment Group. Stuart-Harris RC; Lauchlan R; Day R Med J Aust; 1992 Jun; 156(12):869-72. PubMed ID: 1376397 [TBL] [Abstract][Full Text] [Related]
12. [Treatment with growth factors and cytokines in hematologic diseases]. Waage A; Dahl IM; Evensen SA; Holte H; Lamvik J; Sletnes K; Wisløff F Tidsskr Nor Laegeforen; 1996 May; 116(12):1465-9. PubMed ID: 8650635 [TBL] [Abstract][Full Text] [Related]
13. [Interferon-alpha in the treatment of hematologic neoplasms]. Aulitzky W; Gastl G; Tilg H; Troppmair J; Leiter E; Geissler D; Flener R; Huber C Wien Med Wochenschr; 1986 Apr; 136(7-8):172-81. PubMed ID: 3524022 [TBL] [Abstract][Full Text] [Related]
14. [Interferons. Interferons alpha and gamma: indications in systemic diseases]. Blétry O; Papo T Ann Med Interne (Paris); 1993; 144(8):557-62. PubMed ID: 8179244 [TBL] [Abstract][Full Text] [Related]
15. Current status of interferons in the treatment of cancer. Hansen RM; Borden EC Oncology (Williston Park); 1992 Nov; 6(11):19-24; discussion 26, 29. PubMed ID: 1280153 [TBL] [Abstract][Full Text] [Related]
16. The role of interferons in the treatment of hematologic malignancies. Gutterman JU Semin Hematol; 1988 Jul; 25(3 Suppl 3):3-8. PubMed ID: 2459780 [TBL] [Abstract][Full Text] [Related]
17. The interferons in haematological malignancies. Mandelli F; Arcese W; Avvisati G Baillieres Clin Haematol; 1994 Mar; 7(1):91-113. PubMed ID: 7518713 [TBL] [Abstract][Full Text] [Related]